skip to main content
Global Search Configuration

About Derrick

Washington DC, USA

25+ years of experience

Derrick covers US FDA regulatory and policy issues, helping drug and biologic sponsors and other stakeholders understand the drug development, review and approval landscape.
Derrick focuses on the US FDA user fee programs, regulations and policy for new and generic drugs, biologics and biosimilars, advisory committee and other agency activities, as well as federal legislation and budget matters on Capitol Hill. An award-winning journalist, he was a reporter for several community newspapers and a business journal prior to joining Pharma Intelligence. When not following FDA, Derrick is keeping tabs on Indiana University basketball.

Analyst Articles

Articles by Derrick